© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Dydrogesterone has a long and curious backstory. Decades ago, medical researchers dug deep into female reproductive health and quickly realized natural progesterone, though essential, wasn’t always ideal as a treatment. Early synthetic versions gave rough side effects, largely because the body metabolized them inefficiently. In the 1950s and 60s, drug makers put chemistry to work, trying to craft a molecule that acted like natural progesterone without the unpredictability. That’s how dydrogesterone came to the market. Researchers, most notably in Europe, wanted a compound that could handle menstrual irregularities, embryo implantation, and pregnancy support, but without harsh "male hormone" side effects. Over fifty years, doctors have prescribed dydrogesterone for a range of gynecological needs, and it’s earned a reputation for precise action and good safety.
Dydrogesterone shows up most frequently as round, white tablets that slide easily into standard pharmaceutical packaging. Dose sizes vary, but 10 mg seems most common. Each tablet carries this synthetic progestogen, sometimes with lactose or cellulose, for stability and simplicity. Manufacturers stamp clear markings. You’ll spot these drugs on shelves under several brand names, but the function stays the same: mimic the action of natural progesterone, minus some metabolic baggage. Pharmacists point out that dydrogesterone fits neatly into oral regimens, unlike some other progestogens that barely absorb well or need injections.
Dydrogesterone comes as a white or almost white powder, barely soluble in water but dissolving well in most organic solvents. The molecular formula is C21H28O3, and its chemical structure echoes progesterone, except with one double bond extra, anchoring the “retro” style of this hormone. Under the microscope, it looks neat and granular, melting around 196–201°C. These features let chemists recognize the compound quickly and give pharmacists an easy time keeping formulation consistent. The powder’s mild odor, lack of taste, and decent shelf life all make manufacturing more practical.
Pharmaceutical-grade dydrogesterone passes rigid quality tests before landing in clinics. Each batch gets analyzed for purity—way above 98% per pharmacopeia rules. Labels on the box tell you the active content, storage conditions (keep cool and dry), shelf life (often three to five years), warnings (don’t use beyond date), and instructions. Clinical trials and ongoing lab work shape updates to these specs. There’s a bar code, batch number, and a long leaflet for patients and doctors spelling out risks or proper usage, which helps cut mistakes in real-world settings.
Manufacturing dydrogesterone pulls from classic steroid chemistry and some newer purification tricks. Starting with plant sterols or diosgenin from wild yam or soy, labs use a multi-step synthesis loaded with hydrogenations, selective oxidations, and careful control of double bonds. Skilled chemists guide the transformation, isolating intermediates, and making sure no by-products sneak into the final stuff. Purification—mainly crystallization and chromatography—pulls out the pure hormone. Over the years, batch yields have climbed and consistency has tightened, trimming costs and dialing up supply chain reliability.
Every tweak to dydrogesterone's structure changes how it behaves in the body. The vital "retro" double bond gives the molecule its unique receptor affinity. Medicinal chemists often try minor substitutions on the steroid backbone, looking for better bioavailability, less metabolism in the liver, or even longer half-life. Modifications can add bulky groups that block enzymes or push the molecule to bind even more tightly to the progesterone receptor, but the original dydrogesterone structure still wins out for a balanced safety-effectiveness mix. The laboratory work keeps the hormone stable and predictable, not something you can say for all historic progestogens.
International markets know dydrogesterone by several names. In Europe, Duphaston leads the pack, while Asia sees a few different brands. You’ll spot synonyms like 6-dehydro-9β,10α-progesterone, or sometimes just "retroprogesterone" in academic papers. Each name and trademark plays into regional preferences, but doctors and pharmacists track the same hormone action regardless of the brand logo.
Regulatory agencies across the globe scrutinize dydrogesterone’s safety with a sharp eye. Clinical guidelines steer away from using it in women with hormone-dependent cancers, blood clotting issues, or certain liver conditions. Tablets land in tamper-evident packs and follow campaigns warning about potential side effects: headache, dizziness, rare skin reactions, or breakthrough bleeding. Compared to early progestins, side effect rates look low. Proper use means careful medical supervision, especially for long-term or pregnancy-support regimens. During manufacturing, good laboratory practices, cross-contamination control, and worker training stand as the main lines of defense against dosing errors or adulteration.
Dydrogesterone appeals to clinicians dealing with infertility, threatened pregnancy loss, irregular menstruation, or hormone replacement in menopause. Its selective binding means less risk of pushing androgen-like symptoms—acne, oily skin, or unwanted hair growth. Endometriosis, premenstrual syndrome, miscarriage risk, and part of IVF cycles all rank among the usual targets. Some settings use dydrogesterone to support full-term pregnancy in women with a knack for recurrent miscarriage. Doctors in over a hundred countries rely on it, not just for preference, but due to documented success in peer-reviewed studies and decades of reasonably clear safety.
Research into dydrogesterone hasn’t stopped at its first uses. In the last decade, academic teams and drug companies dove into how the molecule works inside uterine tissue, how it interacts with genetic signals, and whether it might help beyond gynecology. Ongoing trials keep looking at its part in new IVF protocols, unexplained infertility, and adjunct therapy for endometriosis. Some investigators study patient genetics to see if some women respond better than others. Pharmaceutical companies keep hunting for ways to make formulations more patient-friendly, including slow-release forms that demand less strict pill schedules. This wave of research still uses big sample sizes, aiming to untangle nuanced hormone effects for tomorrow’s therapies.
Toxicologists spent years putting dydrogesterone through rigorous scrutiny. In animal studies, the compound does not cause mutations, and teratogenic risks seem smaller than with older progestins. Doses far beyond clinical ranges can stress certain organs, especially liver and kidneys, but human reports of toxicity at prescribed levels stay rare. Watchdogs track chronic use, especially in early pregnancy, to catch any rare complications. Pregnant women and their babies landed under scientific microscopes in extensive registries, but findings so far line up with a solid safety story. Dydrogesterone’s short half-life means it doesn’t pile up in the body—another advantage for safety over time.
Looking ahead, there’s still plenty of runway for dydrogesterone. Demand for safer, better-tolerated hormone therapy keeps rising across the globe. As societies delay childbearing, more patients need fertility support or pregnancy maintenance therapies with proven track records. Personalized medicine’s growth sparks new research into individual response differences, potentially uncovering markers that point to women who’d benefit most or need alternative dosing. Pharmaceutical innovation constantly pushes for more convenient and patient-centered hormone treatments, and dydrogesterone’s oral route, clean metabolic profile, and predictable action check the right boxes for modern clinical needs. Whether future breakthroughs reshape gynecology or expand into new areas, researchers keep dydrogesterone in the running as a backbone of reproductive medicine.
Millions of women bump into hormone-related health problems at some point in their lives. From painful periods to trouble carrying a pregnancy, the struggle feels real. Dydrogesterone, a synthetic form of the hormone progesterone, steps in as a critical option in a world with limited answers for these issues. This medication stands apart from earlier progesterone drugs. It’s chemically close to natural progesterone, with fewer side effects, and comes in an easy-to-take tablet. That’s a big deal, especially for those who can’t tolerate older treatments or want to avoid hormone injections.
Women trying to overcome recurrent miscarriage often find themselves searching for answers. Research published in journals like The Lancet has shown that women with at least one previous miscarriage and early pregnancy bleeding see improved outcomes with dydrogesterone. For someone who’s been through the pain of multiple losses, hearing that a pill could increase the chance of holding their baby matters on a different level.
Irregular menstrual cycles throw off routines and can create anxiety about fertility. Dydrogesterone offers doctors a tool to correct this, providing much-needed cycle regularity. Unlike some hormone options linked with unwanted hair growth or weight gain, dydrogesterone gets the job done without adding unrelated hormonal effects. These differences help women stick with the treatment longer, leading to better results.
Endometriosis brings chronic pain and even infertility. In these cases, doctors turn to dydrogesterone for its ability to suppress the growth of painful tissue outside the uterus. Clinical research suggests that regular use reduces pain scores for many sufferers. While this won’t cure the disease, it provides real relief that improves daily life—something folks with endometriosis fight for every day.
Premenstrual syndrome also plagues women. Real stories fill internet forums about mood swings and physical pain every month. Here, dydrogesterone helps even out the body’s hormone swings, offering a calmer mind and an easier time at work and home. Having lived in a house with sisters, I saw how these monthly symptoms could derail normal life. A treatment that helps with this problem deserves attention.
Menopause arrives with its assortment of symptoms and risks. Women on hormone replacement therapy use estrogen to stay healthy, but this benefit comes with risk if used alone for those with a uterus — the growth of the uterine lining can lead to cancer. Here, dydrogesterone balances estrogen’s action, protecting the womb and making hormone therapy safer. Guidelines from professional societies like the North American Menopause Society back this approach.
A huge health gap remains in many countries, where some women lack access to quality gynecological care. Dydrogesterone can play a part in closing that gap, because it’s a straightforward oral medicine. Bringing affordable, reliable treatments like this to more clinics could raise the standard of women’s care everywhere. Education matters too—many people don’t realize painful, irregular, or heavy periods aren’t just something to bear in silence. By informing patients and broadening healthcare training, more women can find help.
The importance of dydrogesterone runs beyond its chemical structure. It offers hope during some of life’s toughest moments. Anyone dealing with women’s health issues should know this option, speak openly with their doctor, and look for reliable information, not just hearsay or outdated myths. Real-world progress always starts with honest conversations, patient questions, and healthcare systems willing to change.
Dydrogesterone stands out as a synthetic hormone that doctors prescribe for issues such as irregular periods, endometriosis, or recurrent miscarriages. It works in ways that help balance the body’s own hormones. My years covering medical stories and speaking with patients have shown me that every drug comes with trade-offs. There is no skipping this fact.
Most people tolerate dydrogesterone quite well. A lot of women get through a course with few complaints. Still, there are side effects that lead some to tell their doctors, “I don’t feel right.” Common issues include headaches, nausea, bloating, and breast tenderness. Some women share that they feel dizzy or tired after starting the tablets. One nurse told me that about one in ten patients mention digestive troubles, like mild stomach pain or changes to bowel habits. These issues tend to sort themselves out after a week or two, but they can catch people off guard.
Hormones shape mood after just a few doses. I have heard stories of women experiencing swings in their emotions or mild depressive spells. While the science points out that most people do not struggle with depression from dydrogesterone, those sensitive to hormone changes may feel off. Open lines of communication help here. Doctors say patients need to be honest if anxiety or sadness creeps up—this is not a time to suffer in silence.
Blood clots rarely come up in healthy women using dydrogesterone, but the risk rises if someone smokes or carries extra weight. Severe allergic reactions remain very rare. Still, things like swelling of the face, trouble breathing, and skin rashes require a call to the doctor. Liver concerns are even less frequent, but some doctors ask for a blood test if a patient has unexplained fatigue, dark urine, or yellowing eyes.
Doctors weigh the benefits and risks by looking at each person’s health history. A woman who has migraine with aura or a history of clots might hear her provider steer her away from dydrogesterone, since safer alternatives exist. This level of caution comes from decades of research and plenty of clinical experience—nobody wants to take gambles with hormone medicines.
The best safety net comes from a well-informed patient. Pharmacists and physicians who spend a little more time explaining what to expect tend to see fewer surprises. A written checklist about what’s normal and what needs a callback really helps. Women share that tracking their symptoms in a journal gives them a sense of control and confidence.
Drug companies and regulators play a role here too. Clearer package inserts, better reporting of new side effects, and patient education campaigns all make a difference. Community groups and online support forums, used responsibly, bring a sense of solidarity to those starting a new medicine. Trust and openness between patients and providers form the core of safe and effective care, especially with hormone therapies like dydrogesterone.
Dydrogesterone supports many women who deal with hormone imbalances. Often prescribed for conditions like irregular periods, endometriosis, or threatened miscarriages, this medication plays a clear role in reproductive medicine. People look for concrete answers about using it right, given the concerns over side effects or missing a dose.
Doctors usually base decisions about dosing on the reason for taking dydrogesterone. Someone coping with period pain might get a different schedule compared to someone using it for fertility support. Tablets commonly come in 10 mg form, and doses can go from one to three times a day. Eating food before or after won’t usually change how well it works.
Based on clinical manuals and real-life patient stories, the best habit to develop is taking the tablet at the same time each day. This regularity keeps hormone levels from spiking or dropping off—something my own patients found helps with side effects like mood swings. Alarm reminders or smartphone apps can take the worry out of forgetting.
Life gets in the way, and pills get missed. For dydrogesterone, skip the missed dose if it’s almost time for the next one. Doubling up the amount in a short window doesn’t help and raises the odds of headaches or dizziness. Consistency, not catch-up, counts most here.
Mixing dydrogesterone with other medications deserves attention. People taking common anti-seizure drugs or antibiotics like rifampicin may see weaker results because of how the body breaks down the hormones. Sharing an updated medication list with your provider avoids preventable issues.
Underlying health concerns, especially liver problems, also need a mention. Studies show that most people handle dydrogesterone well, but anyone with a history of jaundice or serious liver conditions should hear from their doctor about extra monitoring. Spotting yellow skin or severe fatigue early keeps things on track.
Decades of research back the safety of dydrogesterone for supporting pregnancy and cycle regulation. A 2021 review in “Fertility and Sterility” underlined low risks when people stick to doctor-approved instructions. Reported side effects like nausea, breast tenderness, or headaches touch only a minority. The odds of any serious complications sit far below those from older hormone drugs, thanks in part to improved tablet formulations.
Direct communication gives women more control over their care. Pharmacists and online resources help with the “how-to’s,” but asking a doctor about what to expect means fewer surprises along the way. Reporting unusual side effects like heavy vaginal bleeding or sudden chest pain makes a real difference in long-term safety. Keeping a symptom diary sometimes uncovers issues sooner.
Health literacy remains uneven across communities. Where people don’t feel comfortable with prescriptions or struggle with language barriers, the risks go up. Clinics can make a difference by handing out simplified print instructions or adding visual icons to medication packaging. In my own experience, these small changes often mean more women finish their courses without confusion.
Getting the most benefit from dydrogesterone rests on following medical advice instead of generic tips found online. Most women can use this medication safely. Clear instructions, honest feedback to health professionals, and tools that fit busy lives build better outcomes for everyone.
Dydrogesterone gets used pretty often by doctors, especially for women fighting for a healthy pregnancy. This synthetic hormone acts like natural progesterone—one of the big players that helps keep a pregnancy on track, especially in the early weeks. Some doctors turn to it for women who have a history of miscarriages or problems with their natural hormone levels. Given its role, women with threatened miscarriage, irregular cycles, or certain fertility issues might see it pop up on their prescription.
Whenever doctors suggest a drug during pregnancy, parents start asking questions—and rightly so. Women and health workers both want to make sure that anything taken won’t harm the baby or mom. Over the past several decades, researchers have looked at whether dydrogesterone leads to birth defects or causes other harm. Data from large observational studies and clinical trials hasn’t shown an increased risk of malformations compared to women who do not take the drug. The World Health Organization’s 2022 report on maternal medications gave dydrogesterone a cautious nod, saying the data looks solid for most cases, but reminded everyone to stay up-to-date on ongoing research.
Many women in fertility and pregnancy forums talk about taking dydrogesterone, especially those who have struggled with miscarriage. I’ve heard friends and acquaintances mention the relief that comes from a reassuring prescription after weeks of uncertainty. Still, every story is different, and social media can never replace a doctor’s direct advice.
No pregnancy comes without risk, and no drug should get handed out like candy. Dydrogesterone does seem a lot less worrisome than older synthetic hormones that came before it, which sometimes caused problems for babies later in life. Researchers still watch for rare complications, but the numbers so far tell a pretty reassuring story. European guidelines say it offers a good safety profile, especially for women with threatened miscarriage or hormone-related infertility.
Most importantly, doctors weigh the benefit against the risk. The risk of another loss for women with repeated miscarriages often outweighs the risk of dydrogesterone, based on what the data shows. Still, some specialists prefer to check hormone levels and do ultrasounds before prescribing it, since not every pregnancy problem relates to progesterone.
It doesn’t make sense for women to buy dydrogesterone online or take it based on advice from friends. What works for one person won’t always work for another. Safety lies in the hands of a healthcare professional who understands the medical history and monitors progress.
Experts call for more head-to-head research on progesterone drugs, including dydrogesterone, to identify which women really benefit. High-quality, independent trials could help identify rare negative effects missed in smaller studies. National health authorities keep tracking outcomes in large birth registries, looking for patterns and new risks.
Moms and families deserve transparency and ongoing guidance. Doctors already discuss the benefits and unclear areas with their patients. Strong support, access to honest information, and clear communication go a long way to making pregnancies a little less scary when progesterone drugs enter the picture.
Infertility stings. It brings up endless questions, and answers often feel out of reach. For many women, the focus turns to hormones, especially the role of progesterone in keeping a pregnancy steady. Dydrogesterone, a synthetic hormone, claims a spot in this conversation. Unlike some older options, this drug closely mimics natural progesterone without making the body feel sluggish or off-balance. For women whose bodies don’t produce quite enough progesterone, it steps in with the promise of bridging that gap.
Many fertility clinics across Asia and Europe hand out dydrogesterone prescriptions like trusted tools. Clinical studies, with thousands of women enrolled, show that it helps regulate menstrual cycles and supports the uterus in early pregnancy, especially for those struggling with luteal phase defects or recurrent miscarriages. The World Health Organization and several regional guidelines place dydrogesterone as a recommended option for luteal phase support. My colleagues in reproductive medicine point out that their own patients see benefits: regular cycles replace erratic ones, and the heartbreak of miscarriages sometimes gives way to successful pregnancies.
No drug treats every woman equally, and side effects always deserve real talk. Some women experience headaches, breast tenderness, or mild stomach upset with dydrogesterone. Unlike natural progesterone, though, dydrogesterone rarely causes fatigue or grogginess. I’ve listened to patients hesitate, tired of treatments that leave them feeling worse instead of better. For those women, dydrogesterone can make a difference. Still, honest conversations with a trusted provider matter most—especially for anyone with a history of allergies or liver conditions.
Doctors in many regions choose dydrogesterone because it comes in an easy-to-take tablet, doesn’t cause major hormone swings, and avoids oil-based injections. Still, supply remains patchy in North America. The FDA hasn’t approved it, which means American women hunt for other, often less comfortable, alternatives. It’s baffling when a drug trusted elsewhere remains out of reach due to regulatory mazes. Cost also plays a role. Not everyone can afford repeated cycles of fertility medication, especially outside insurance coverage. Professional groups keep calling for wider studies and easier access so that every woman—not just those in certain ZIP codes—can benefit.
Doctors want to balance hope with real science. Dydrogesterone won’t create miracles, but it gives many women a fair shot. What stands out to me is not just lab results but patient stories—couples who made peace with their bodies or who, after years of dashed hopes, finally saw positive test lines. The conversation about infertility never stops, and for many, dydrogesterone brings something rare: a feeling of safety in a process that often feels out of control. More research and sensible policy could help open this option for everyone.
| Names | |
| Preferred IUPAC name | (8S,9β,10α,13α,14β,16β)-16-Ethyl-9,10,13,14-tetrahydro-8,14-methano-3-oxo-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl acetate |
| Other names |
6-dehydro-9β,10α-progesterone 6-una-dehydroprogesterone Duphaston Dydrogesteronum Dydrogesteron Dydrogesterona |
| Pronunciation | /daɪˌdroʊˈdʒɛstərəʊn/ |
| Identifiers | |
| CAS Number | 152-62-5 |
| 3D model (JSmol) | `3DModel:JSmol:CC1(C)CC[C@H]2[C@@H]1CCC3=C2C=CC(=O)CC3` |
| Beilstein Reference | 1204274 |
| ChEBI | CHEBI:4633 |
| ChEMBL | CHEMBL1409 |
| ChemSpider | 2102 |
| DrugBank | DB00378 |
| ECHA InfoCard | 100.038.027 |
| EC Number | EC 3.3.2.5 |
| Gmelin Reference | 1260226 |
| KEGG | D03852 |
| MeSH | D003562 |
| PubChem CID | 3001654 |
| RTECS number | HP1250000 |
| UNII | 2P835XE4FZ |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C21H28O2 |
| Molar mass | 344.444 g/mol |
| Appearance | White to off-white, crystalline powder |
| Odor | Odorless |
| Density | 1.2 g/cm³ |
| Solubility in water | Slightly soluble |
| log P | 2.7 |
| Vapor pressure | 1.19E-09 mmHg |
| Acidity (pKa) | 10.7 |
| Basicity (pKb) | 5.13 |
| Magnetic susceptibility (χ) | -8.2e-6 |
| Dipole moment | 4.44 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 298.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -323.6 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -8424 kJ/mol |
| Pharmacology | |
| ATC code | G03DB01 |
| Hazards | |
| Main hazards | Possible risk of birth defects if used during pregnancy. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | pregnancy:check, lactation:check, liver:warning, kidney:check, driving:check |
| Hazard statements | Dydrogesterone is not classified as hazardous according to GHS (Globally Harmonized System); therefore, it has no specific hazard statements. |
| Precautionary statements | Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. |
| Flash point | 144.8°C |
| Lethal dose or concentration | LD50 (rat, oral): >2000 mg/kg |
| LD50 (median dose) | LD50: 590 mg/kg (rat, oral) |
| NIOSH | JU359O828T |
| PEL (Permissible) | Not established |
| REL (Recommended) | 30 mg daily |
| Related compounds | |
| Related compounds |
Progesterone Hydroxyprogesterone caproate Medroxyprogesterone acetate |
